Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants
暂无分享,去创建一个
N. Pedemonte | C. Castellani | M. Salvi | C. D’Amore | Elvira Sondo | V. Tomati | V. Capurro | Christian Borgo | F. Cresta | C. D'Amore